Very recently, using next-generation sequencing technologies, a novel B-ALL oncogenic driver DUX4/IGH, derived from the insertion of chromosome fragments containing DUX4 gene into the IGH locus, has been reported in ~7% of B-ALL patients [3, 6, 7]. This evidence concerns the gene DUX4 and precursor B-cell acute lymphoblastic leukemia.